重藥控股(000950.SZ):上半年淨利預降33.09%-39.56%
格隆匯 7 月 17日丨重藥控股(000950.SZ)公佈,預計上半年實現歸屬於上市公司股東的淨利潤28,000萬元–31,000萬元,比上年同期下降:33.09%-39.56%。
本報告期業績同比下降主要原因:報告期內,受新型冠狀病毒感染肺炎疫情影響,各地採取了嚴格的防護政策遏制疫情蔓延,物流運輸和醫療門診等情況較同期發生較大變化,對公司的正常經營等產生了消極影響。疫情期間,公司積極主動承擔社會責任,馳援前線,穩步復工復產,全力保障藥品及醫療器械的正常購銷業務;同時克服困難,繼續推進外延式增長。受客户情況變化等原因,2020年上半年公司主營業務增長有所放緩,經營費用同比增加,淨利潤等財務指標較上年同期有一定下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.